triazoles has been researched along with Blood Diseases in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.33) | 18.7374 |
| 1990's | 1 (2.33) | 18.2507 |
| 2000's | 13 (30.23) | 29.6817 |
| 2010's | 22 (51.16) | 24.3611 |
| 2020's | 6 (13.95) | 2.80 |
| Authors | Studies |
|---|---|
| Azizian, NG; Li, Y | 1 |
| Amberg, S; Bokemeyer, C; Christine Wilke, A; Chromik, J; Deppermann, U; Fiedler, W; Ganser, A; Heuser, M; Janning, M; Kebenko, M; Kranich, AL; Modemann, F; Schlipfenbacher, V; Serve, H; Theile, S; Thol, F | 1 |
| Bernardo, V; Fernandez, AJ; Liverman, R; Miles, A; Tippett, A; Yildirim, I | 1 |
| Chen, B; Wan, Y; Wang, J; Xu, JY; Zhou, M; Zhou, RF | 1 |
| Anderson, LD; Arazy, M; Auner, HW; Badros, A; Bahlis, NJ; Benjamin, R; Cavo, M; Chai, Y; Delimpasi, S; Dimopoulos, MA; Dolai, TK; Doronin, V; Facon, T; Garg, M; Gavriatopoulou, M; Grosicki, S; Hajek, R; Jagannath, S; Kauffman, MG; Kriachok, I; Leleu, X; Levy, M; Mateos, MV; Moreau, P; Pour, L; Pylypenko, H; Quach, H; Richardson, PG; Shacham, S; Shah, J; Simonova, M; Sinha, DK; Spicka, I; Stevens, DA; Usenko, G; Venner, CP | 1 |
| Chen, H; Chen, X; Deng, Q; Gao, S; Hu, J; Hu, Y; Huang, X; Jin, J; Li, J; Lin, D; Liu, L; Liu, Q; Shao, Z; Shen, J; Sun, Z; Wang, C; Wang, J; Wang, S; Wei, X; Wu, D; Wu, X; Yang, J; Zhang, X | 1 |
| Hoenigl, M; Krause, R; Neumeister, P; Prattes, J; Wölfler, A | 1 |
| Boussiou, Z; Johnson, EM; Louka, A; Markantonatou, AM; Oliver, DA; Vyzantiadis, TA; Yannaki, E; Zachrou, E | 1 |
| Brüggemann, RJ; Cordonnier, C; Cornely, OA; Duarte, RF; Girmenia, C; Kibbler, CC; Ljungman, P; Maertens, JA; Peter Donnelly, J; Racil, Z; Ribaud, P; Slavin, MA | 1 |
| de Boer, MGJ; van de Peppel, RJ; van der Beek, MT; Visser, LG; Wallinga, J | 1 |
| Cid, J; Díaz, M; Palomera, L; Solano, F; Zamora, C | 1 |
| Kontoghiorghes, GJ | 1 |
| Chirnomas, D; Esposito, J; Giardina, PJ; Goldberg, SL; Paley, C; Vichinsky, E | 1 |
| Busca, A; Caira, M; Candoni, A; Cesaro, S; Cornely, OA; Gasbarrino, C; Girmenia, C; Heinz, WJ; Herbrecht, R; Lass-Flörl, C; Nosari, A; Pagano, L; Potenza, L; Racil, Z; Rickerts, V; Sheppard, DC; Simon, A; Ullmann, AJ; Valentini, CG; Vehreschild, JJ; Vehreschild, MJ | 1 |
| Engelhardt, M; Gross, BN; Ihorst, G; Jung, M; Wäsch, R | 1 |
| Campoli, P; Duarte, RF; Sheppard, DC | 1 |
| Biehl, LM; Bücker, V; Cornely, OA; Franke, B; Liss, B; Markiefka, B; Persigehl, T; Scheid, C; Vehreschild, JJ; Vehreschild, MJ; Wisplinghoff, H | 1 |
| Al Zoebie, A; Bruederle, A; Chotsampancharoen, T; El-Beshlawy, A; Elalfy, M; Gilotti, G; Han, J; Kamdem, A; Koussa, S; Vichinsky, E | 1 |
| Cappellini, MD; Porter, JB; Taher, AT; Vichinsky, EP | 1 |
| Bagnardi, V; Balduzzi, A; Bertolini, F; Cardillo, A; Colleoni, M; Goldhirsch, A; Mancuso, P; Montagna, E; Orlando, L; Scarano, E; Torrisi, R; Veronesi, P; Viale, G | 1 |
| Aversa, F; Cesaro, S; Milano, GM | 1 |
| Alvarez, MA; Gómez, P; Martín, C; Martín, V; Martínez, F; Molina, JR; Rodríguez, G; Rodríguez-Villa, A; Rojas, R; Sánchez-García, J; Serrano, J; Tallón, D; Torres, A | 1 |
| Arda, B; Ceylan, N; Erdem, A; Işıkgöz Taşbakan, M; Metin, DY; Midilli, R; Pullukçu, H; Sipahi, OR; Taşbakan, MS; Ulusoy, S; Yamazhan, T | 1 |
| Buresova, L; Cetkovsky, P; Kocmanova, I; Kouba, M; Lengerova, M; Malaskova, L; Mayer, J; Racil, Z; Rolencova, M; Timilsina, S; Toskova, M; Weinbergerova, B; Winterova, J; Zak, P | 1 |
| Egerer, G | 1 |
| Bijleveld, YA; Brüggemann, RJ; Crombag, MR; Huisman, C; Kemper, EM | 1 |
| Brown, GC; Patton, WN; St Pierre, TG; Tapp, HE; Taylor, DJ | 1 |
| Cappellini, MD; Hoffbrand, AV; Taher, A | 1 |
| Aydinok, Y; Chan, LL; El-Beshlawy, A; Elalfy, MS; Habr, D; Lee, SH; Martin, N; Porter, JB; Sutcharitchan, P; Taher, AT | 1 |
| Ding, Y; Diong, CP; Hsu, LY; Jin, J; Lim, ZY; Low, CY; Ong, WC; Wong, E | 1 |
| Bennett, JE; Caillot, D; Chandrasekar, PH; de Pauw, B; Denning, DW; Durand, C; Greene, RE; Herbrecht, R; Hodges, MR; Kern, WV; Lortholary, O; Marr, KA; Oestmann, JW; Patterson, TF; Ribaud, P; Rubin, RH; Schlamm, HT; Stark, P; Sylvester, R; Thiel, E; Troke, PF; Wingard, JR | 1 |
| Chevallier, P; Dubruille, V; Guillaume, T; Harousseau, JL; Mahé, B; Méchinaud, F; Milpied, N; Moreau, P; Morin, O; Morineau, N; Vigouroux, S | 1 |
| de Marie, S; den Hollander, JG; Levin, MD; Lugtenburg, PJ; Rijnders, BJ; van Arkel, C | 1 |
| Arndt, M; Cornely, OA; Müller, C; Queckenberg, C; Theisohn, M | 1 |
| Stumpf, JL | 1 |
| Harkness, J; Marriott, D; Milliken, S; Stark, D | 1 |
| Maggio, A | 1 |
| Jarque, I; Sanz, MA | 1 |
| Vichinsky, E | 1 |
| Hampton, T | 1 |
| Burstein, HJ; Winer, EP | 1 |
| Becher, R; Beelen, DW; Ehrlich, R; Grosse-Wilde, H; Quabeck, K; Schaefer, UW; Schilcher, RB; Schmidt, U; Szy, D | 1 |
| Berdel, WE; Bremer, K; Peukert, M; Queisser, W; Wander, HE | 1 |
9 review(s) available for triazoles and Blood Diseases
| Article | Year |
|---|---|
XPO1-dependent nuclear export as a target for cancer therapy.
Topics: Active Transport, Cell Nucleus; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Exportin 1 Protein; Forecasting; Gastrointestinal Diseases; Hematologic Diseases; Humans; Hydrazines; Karyopherins; Molecular Targeted Therapy; Neoplasm Proteins; Receptors, Cytoplasmic and Nuclear; RNA, Neoplasm; Triazoles | 2020 |
Comparison of Antifungal Prophylaxis Drugs in Patients With Hematological Disease or Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review and Network Meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Pre-Exposure Prophylaxis; Triazoles; Voriconazole | 2020 |
European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia.
Topics: Adult; Antifungal Agents; Congresses as Topic; Europe; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Invasive Fungal Infections; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risk Factors; Triazoles | 2018 |
Posaconazole therapeutic drug monitoring in the real-life setting: a single-center experience and review of the literature.
Topics: Academic Medical Centers; Administration, Oral; Adult; Age Factors; Aged; Antifungal Agents; Drug Monitoring; Female; Hematologic Diseases; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Mycoses; Prospective Studies; Risk Factors; Triazoles; Young Adult | 2013 |
Deferasirox.
Topics: Adult; Benzoates; Child; Deferasirox; Deferoxamine; Hematologic Diseases; Hemosiderosis; Humans; Iron; Iron Chelating Agents; Iron Overload; Patient Compliance; Siderophores; Transfusion Reaction; Triazoles | 2007 |
Light and shadows in the iron chelation treatment of haematological diseases.
Topics: Benzoates; Chelation Therapy; Deferasirox; Deferiprone; Deferoxamine; Hematologic Diseases; Humans; Iron Chelating Agents; Iron Overload; Liver; Pyridones; Triazoles | 2007 |
[Current indications for voriconazole in onco-hematological patients].
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Drug Resistance, Fungal; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Multicenter Studies as Topic; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Salvage Therapy; Spain; Triazoles; Voriconazole; Zygomycosis | 2007 |
Clinical application of deferasirox: practical patient management.
Topics: Administration, Oral; Adult; Benzoates; Chemical and Drug Induced Liver Injury; Child; Clinical Trials as Topic; Contraindications; Creatinine; Deferasirox; Disease Management; Drug Eruptions; Gastrointestinal Diseases; Hematologic Diseases; Hemosiderosis; Humans; Iron; Iron Chelating Agents; Iron Overload; Kidney Diseases; Transfusion Reaction; Triazoles | 2008 |
New combinations with Herceptin in metastatic breast cancer.
Topics: Anastrozole; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclophosphamide; Deoxycytidine; Doxorubicin; Drug Interactions; Drug Synergism; Epirubicin; Female; Fluorouracil; Gemcitabine; Heart Diseases; Hematologic Diseases; Humans; Methotrexate; Neoplasm Metastasis; Nitriles; Organoplatinum Compounds; Paclitaxel; Tamoxifen; Thiotepa; Trastuzumab; Treatment Outcome; Triazoles; Vinblastine; Vinorelbine | 2001 |
4 trial(s) available for triazoles and Blood Diseases
| Article | Year |
|---|---|
A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Gastrointestinal Diseases; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Idarubicin; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Progression-Free Survival; Recurrence; Salvage Therapy; Triazoles | 2020 |
The palatability and tolerability of deferasirox taken with different beverages or foods.
Topics: Adolescent; Benzoates; Beverages; Blood Transfusion; Child; Child, Preschool; Deferasirox; Female; Food; Food-Drug Interactions; Hematologic Diseases; Hemosiderosis; Humans; Iron Chelating Agents; Male; Triazoles | 2013 |
Voriconazole as primary antifungal prophylaxis in children undergoing allo-SCT.
Topics: Acute Disease; Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Male; Mycoses; Pyrimidines; Stem Cell Transplantation; Time Factors; Triazoles; Voriconazole | 2012 |
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Female; Hematologic Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Pyrimidines; Survival Rate; Triazoles; Voriconazole | 2002 |
30 other study(ies) available for triazoles and Blood Diseases
| Article | Year |
|---|---|
Initial posaconazole dosing to achieve therapeutic serum posaconazole concentrations among children, adolescents, and young adults receiving delayed-release tablet and intravenous posaconazole.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Body Weight; Child; Child, Preschool; Delayed-Action Preparations; Female; Hematologic Diseases; Humans; Immunocompromised Host; Infusions, Intravenous; Invasive Fungal Infections; Male; Neoplasms; Retrospective Studies; Tablets; Treatment Outcome; Triazoles; Young Adult | 2020 |
Effect of age and frailty on the efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Clinical Trials, Phase III as Topic; Dexamethasone; Drug Administration Schedule; Female; Frailty; Gastrointestinal Diseases; Hematologic Diseases; Humans; Hydrazines; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Multiple Myeloma; Peripheral Nervous System Diseases; Progression-Free Survival; Randomized Controlled Trials as Topic; Retrospective Studies; Severity of Illness Index; Triazoles | 2021 |
Real-world assessment of the effectiveness of posaconazole for the prophylaxis and treatment of invasive fungal infections in hematological patients: A retrospective observational study.
Topics: Adult; Antifungal Agents; Female; Hematologic Diseases; Humans; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Triazoles; Young Adult | 2021 |
Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study.
Topics: Amphotericin B; Anemia, Aplastic; Antifungal Agents; Aspergillus; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Male; Neutropenia; Nitriles; Pyridines; Transaminases; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2018 |
Alternative approaches to the therapeutic drug monitoring of prophylactic posaconazole in haematology patients.
Topics: Administration, Oral; Adult; Antifungal Agents; Biological Assay; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Hematologic Diseases; Humans; Male; Middle Aged; Triazoles | 2018 |
Managing invasive aspergillosis in haematological patients in the era of resistance polymerase chain reaction and increasing triazole resistance: A modelling study of different strategies.
Topics: Antifungal Agents; Aspergillus; Bronchoalveolar Lavage Fluid; Computer Simulation; Diagnostic Tests, Routine; Disease Management; Drug Resistance, Fungal; Drug-Related Side Effects and Adverse Reactions; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Polymerase Chain Reaction; Treatment Outcome; Triazoles | 2019 |
Clinical characteristics and management of iron overload in 631 patients with chronic transfusion dependency: results from a multicentre, observational study.
Topics: Aged; Benzoates; Chelation Therapy; Comorbidity; Deferasirox; Disease Management; Erythrocyte Transfusion; Female; Ferritins; Guideline Adherence; Hematologic Diseases; Humans; Iron; Iron Chelating Agents; Iron Overload; Male; Middle Aged; Practice Guidelines as Topic; Spain; Transfusion Reaction; Triazoles | 2014 |
Turning a blind eye to deferasirox's toxicity?
Topics: Age Factors; Benzoates; Cause of Death; Chronic Disease; Deferasirox; Drug Approval; Europe; Hematologic Diseases; Humans; Iron Chelating Agents; Iron Overload; Triazoles | 2013 |
Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Follow-Up Studies; Hematologic Diseases; Humans; Mucormycosis; Registries; Treatment Outcome; Triazoles | 2013 |
Understanding antifungal prophylaxis with posaconazole in hematology patients: an evolving bedside to bench story.
Topics: Antifungal Agents; Chemoprevention; Hematologic Diseases; Humans; Mycoses; Triazoles | 2014 |
A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Cohort Studies; Echinocandins; Female; Hematologic Diseases; Humans; Incidence; Invasive Fungal Infections; Itraconazole; Lipopeptides; Male; Micafungin; Middle Aged; Triazoles; Young Adult | 2016 |
Long-term safety and efficacy of deferasirox in young pediatric patients with transfusional hemosiderosis: Results from a 5-year observational study (ENTRUST).
Topics: Benzoates; Chelation Therapy; Child, Preschool; Deferasirox; Female; Hematologic Diseases; Hemosiderosis; Humans; Iron Chelating Agents; Male; Transfusion Reaction; Triazoles | 2017 |
Ethical issues and risk/benefit assessment of iron chelation therapy: advances with deferiprone/deferoxamine combinations and concerns about the safety, efficacy and costs of deferasirox [Kontoghiorghes GJ, Hemoglobin 2008; 32(1-2):1-15.].
Topics: Benzoates; Chelation Therapy; Deferasirox; Deferiprone; Deferoxamine; Drug Costs; Drug-Related Side Effects and Adverse Reactions; Hematologic Diseases; Humans; Iron Chelating Agents; Pyridones; Risk Assessment; Siderophores; Triazoles | 2008 |
Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Carcinoma; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hematologic Diseases; Humans; Hypertension; Infusions, Intravenous; Letrozole; Mastectomy; Middle Aged; Nitriles; Paclitaxel; Prognosis; Proteinuria; Radiotherapy, Adjuvant; Triazoles | 2009 |
Retrospective survey on the off-label use of posaconazole in pediatric hematology patients.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Hematologic Diseases; Humans; Mycoses; Off-Label Use; Retrospective Studies; Treatment Outcome; Triazoles | 2011 |
[Mucormycosis: retrospective evaluation of 12 cases].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Brain Diseases; Diabetes Complications; Female; Hematologic Diseases; Humans; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Nose Diseases; Orbital Diseases; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2011 |
Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Monitoring; Female; Hematologic Diseases; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
[Ambulatory therapy of aspergillosis in hematological and oncological patients].
Topics: Ambulatory Care; Antifungal Agents; Caspofungin; Echinocandins; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Neutropenia; Pyrimidines; Salvage Therapy; Triazoles; Voriconazole | 2012 |
Posaconazole treatment in hematology patients: a pilot study of therapeutic drug monitoring.
Topics: Adult; Antifungal Agents; Drug Monitoring; Female; Follow-Up Studies; Hematologic Diseases; Humans; Male; Middle Aged; Mycoses; Pilot Projects; Retrospective Studies; Treatment Outcome; Triazoles | 2012 |
Spin density projection-assisted R2 magnetic resonance imaging of the liver in the management of body iron stores in patients receiving multiple red blood cell transfusions: an audit and retrospective study in South Australia.
Topics: Adolescent; Adult; Aged; Benzoates; Chelation Therapy; Child; Deferasirox; Deferoxamine; Erythrocyte Transfusion; Female; Ferritins; Hematologic Diseases; Hemosiderosis; Humans; Infant; Infusions, Intravenous; Injections, Subcutaneous; Iron; Iron Chelating Agents; Liver; Magnetic Resonance Imaging; Male; Medical Audit; Middle Aged; Retrospective Studies; ROC Curve; Sensitivity and Specificity; South Australia; Triazoles | 2012 |
How I treat transfusional iron overload.
Topics: Benzoates; Deferasirox; Deferiprone; Deferoxamine; Hematologic Diseases; Humans; Iron Chelating Agents; Iron Overload; Pyridones; Transfusion Reaction; Triazoles | 2012 |
Efficacy and safety of deferasirox at low and high iron burdens: results from the EPIC magnetic resonance imaging substudy.
Topics: Adolescent; Adult; Benzoates; Chelation Therapy; Child; Child, Preschool; Cholelithiasis; Clinical Trials, Phase III as Topic; Creatinine; Deferasirox; Edema; Ethnicity; Female; Ferritins; Gastrointestinal Diseases; Hematologic Diseases; Hepatitis, Viral, Human; Humans; Infant; Iron; Iron Chelating Agents; Iron Overload; Kidney Diseases; Liver; Magnetic Resonance Imaging; Male; Multicenter Studies as Topic; Prospective Studies; Thalassemia; Transfusion Reaction; Triazoles; Young Adult | 2013 |
Real-world experience with posaconazole prophylaxis in high-risk hematological patients in Singapore: a prospective audit.
Topics: Administration, Oral; Adult; Antifungal Agents; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Medical Audit; Middle Aged; Mycoses; Prospective Studies; Singapore; Treatment Outcome; Triazoles | 2013 |
Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required.
Topics: Absidia; Adult; Antifungal Agents; Child, Preschool; Female; Hematologic Diseases; Humans; Immunocompromised Host; Male; Middle Aged; Mucormycosis; Pyrimidines; Rhizomucor; Rhizopus; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Incidence of voriconazole hepatotoxicity during intravenous and oral treatment for invasive fungal infections.
Topics: Administration, Oral; Antifungal Agents; Hematologic Diseases; Humans; Injections, Intravenous; Liver; Liver Function Tests; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2006 |
HPLC analysis of the antifungal agent posaconazole in patients with haematological diseases.
Topics: Antifungal Agents; Biological Availability; Chromatography, High Pressure Liquid; Drug Monitoring; Hematologic Diseases; Humans; Mycoses; Triazoles | 2006 |
Rhizopus microsporus var. rhizopodiformis sinus-orbital zygomycosis in an immunosuppressed patient: successful treatment with posaconazole after a complicated clinical course.
Topics: Adult; Amphotericin B; Eye Infections, Fungal; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Orbital Diseases; Paranasal Sinus Diseases; Rhizopus; Soil; Soil Microbiology; Transplantation, Homologous; Triazoles; Zygomycosis | 2007 |
Strides made in red blood cell disorders, but substantial barriers to care remain.
Topics: Anemia, Sickle Cell; Antisickling Agents; Benzoates; Brain Diseases; Chelation Therapy; Deferasirox; Hematologic Diseases; Hematology; Humans; Hydroxyurea; Iron Chelating Agents; Triazoles | 2008 |
High-dose 1,2,4-triglycidylurazol given in regimens preparatory to bone marrow transplantation. A preclinical pharmacology study.
Topics: Animals; Antineoplastic Agents; Bone Marrow Transplantation; Busulfan; Dogs; Drug Evaluation, Preclinical; Gastrointestinal Diseases; Hematologic Diseases; Triazoles; Whole-Body Irradiation | 1991 |
1,2,4-Triglycidylurazol in advanced breast cancer: a trial of the phase II study group of the Association of Medical Oncology, German Cancer Society.
Topics: Adult; Aged; Breast Neoplasms; Drug Evaluation; Female; Hematologic Diseases; Humans; Middle Aged; Triazoles | 1987 |